2001
DOI: 10.1046/j.1365-2249.2001.01483.x
|View full text |Cite
|
Sign up to set email alerts
|

The impact of platelet-activating factor (PAF)-like mediators on the functional activity of neutrophils: anti-inflammatory effects of human PAF-acetylhydrolase

Abstract: SUMMARYPlatelet-activating factor (PAF) is a proinflammatory agent in infectious and inflammatory diseases, partly due to the activation of infiltrating phagocytes. PAF exerts its actions after binding to a monospecific PAF receptor (PAFR). The potent bioactivity is reflected by its ability to activate neutrophils at picomolar concentrations, as defined by changes in levels of intracellular Ca 21 ([Ca 21 ] i ), and induction of chemotaxis and actin polymerization at nanomolar concentration. The role of PAF in… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
9
0
2

Year Published

2002
2002
2023
2023

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 23 publications
(12 citation statements)
references
References 50 publications
1
9
0
2
Order By: Relevance
“…Indeed, in line with our results, DMF was previously suggested to inhibit NET formation in murine autoimmune blistering disease . Notably, we demonstrate that this modulation is stimulus specific: while PMA‐induced, Nox‐dependent NET formation was inhibited, PAF‐ and ionomycin‐induced, probably Nox‐independent NET formation was not inhibited.…”
Section: Discussionsupporting
confidence: 91%
See 1 more Smart Citation
“…Indeed, in line with our results, DMF was previously suggested to inhibit NET formation in murine autoimmune blistering disease . Notably, we demonstrate that this modulation is stimulus specific: while PMA‐induced, Nox‐dependent NET formation was inhibited, PAF‐ and ionomycin‐induced, probably Nox‐independent NET formation was not inhibited.…”
Section: Discussionsupporting
confidence: 91%
“…S1c; see Supporting Information). Notably, DMF also did not affect NET formation induced by PAF, which was shown to be incapable of activating Nox without cofactors (see Fig. e).…”
Section: Resultsmentioning
confidence: 86%
“…A possible relationship between PAF‐mediated mobilization of Ca 2+ and ‘priming’ of neutrophils for activation with a second stimulus is supported by the observations that dibutyryl cyclic AMP, CGS 21680 and rolipram all attenuated the sensitizing effects of PAF on FMLP/CB‐activated release of elastase by the cells. These findings also suggest that cyclic AMP‐elevating agents, presumably by enhancement of clearance of Ca 2+ from the cytosol of activated neutrophils, may represent a possible therapeutic alternative to PAF‐receptor antagonists and ‐hydrolyzing enzymes (Kuijpers et al ., 2001).…”
Section: Discussionmentioning
confidence: 94%
“…Moreover, over-expression of either the plasma (43)(44)(45) or liver type II (14,46) PAF-AH blocks apoptosis in response to diverse physiologic and pharmacologic agents. The clear implication of these data is that the short-chain phospholipid substrates of these enzymes are distinctly proapoptotic and that these lipids play a large part in regulated cell death.…”
Section: Apoptosismentioning
confidence: 99%